These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 21827445

  • 1. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L, Zhu J, Brink PR, Glass PS, Rebecchi MJ.
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [Abstract] [Full Text] [Related]

  • 2. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D, Wynne A, Duchen M, Yellon D.
    Circulation; 2004 Apr 13; 109(14):1714-7. PubMed ID: 15066952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion.
    Xie JR, Yu LN.
    Acta Anaesthesiol Scand; 2007 Aug 13; 51(7):909-13. PubMed ID: 17578461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G, Matoba T, Nakano Y, Nagaoka K, Ishikita A, Nakano K, Funamoto D, Sunagawa K, Egashira K.
    Sci Rep; 2016 Feb 10; 6():20467. PubMed ID: 26861678
    [Abstract] [Full Text] [Related]

  • 7. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.
    Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M.
    J Mol Cell Cardiol; 2005 Feb 10; 38(2):367-74. PubMed ID: 15698843
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardiomyocytes.
    Assaly R, de Tassigny Ad, Paradis S, Jacquin S, Berdeaux A, Morin D.
    Eur J Pharmacol; 2012 Jan 30; 675(1-3):6-14. PubMed ID: 22173126
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore.
    Gharanei M, Hussain A, Janneh O, Maddock HL.
    Toxicol Appl Pharmacol; 2013 Apr 15; 268(2):149-56. PubMed ID: 23262186
    [Abstract] [Full Text] [Related]

  • 10. Enhanced cell-volume regulation in cyclosporin A cardioprotection.
    Diaz RJ, Fernandes K, Lytvyn Y, Hawrylyshyn K, Harvey K, Hossain T, Hinek A, Wilson GJ.
    Cardiovasc Res; 2013 Jun 01; 98(3):411-9. PubMed ID: 23483048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM.
    Eur J Pharmacol; 2012 Jan 30; 675(1-3):40-6. PubMed ID: 22166375
    [Abstract] [Full Text] [Related]

  • 13. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
    Ruiz-Meana M, Abellán A, Miró-Casas E, Garcia-Dorado D.
    Basic Res Cardiol; 2007 Nov 30; 102(6):542-52. PubMed ID: 17891523
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial pores modulate the protective effect of acetylcholine on ventricular myocytes during ischemia/reperfusion injury.
    Sun GQ, Wang J, Li Q, Ye ZG, Xia Q.
    Methods Find Exp Clin Pharmacol; 2010 Mar 30; 32(2):107-12. PubMed ID: 20401347
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine A normalizes mitochondrial coupling, reactive oxygen species production, and inflammation and partially restores skeletal muscle maximal oxidative capacity in experimental aortic cross-clamping.
    Pottecher J, Guillot M, Belaidi E, Charles AL, Lejay A, Gharib A, Diemunsch P, Geny B.
    J Vasc Surg; 2013 Apr 30; 57(4):1100-1108.e2. PubMed ID: 23332985
    [Abstract] [Full Text] [Related]

  • 16. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS, Krolikowski JG.
    Anesth Analg; 2009 Apr 30; 108(4):1076-82. PubMed ID: 19299764
    [Abstract] [Full Text] [Related]

  • 17. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
    Gao Q, Zhang SZ, Cao CM, Bruce IC, Xia Q.
    Cytokine; 2005 Dec 07; 32(5):199-205. PubMed ID: 16260145
    [Abstract] [Full Text] [Related]

  • 18. Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore.
    Dorsch M, Behmenburg F, Raible M, Blase D, Grievink H, Hollmann MW, Heinen A, Huhn R.
    PLoS One; 2016 Dec 07; 11(3):e0151025. PubMed ID: 26968004
    [Abstract] [Full Text] [Related]

  • 19. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN, Zhou ZM, Chen P.
    Clin Exp Pharmacol Physiol; 2008 Feb 07; 35(2):211-6. PubMed ID: 17941891
    [Abstract] [Full Text] [Related]

  • 20. Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury.
    Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ, Yellon DM.
    J Cardiovasc Pharmacol Ther; 2011 Mar 07; 16(1):63-71. PubMed ID: 21183727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.